Allscripts Announces Allscripts eRecruit, New Initiative to Improve Population Health

AllscriptsAllscripts (NASDAQ:MDRX) announced today its latest initiative to improve population health, Allscripts eRecruitTM services. This multi-faceted initiative will offer services and technology to support physicians with referring patients to clinical trials, and life sciences and clinical research organizations to reduce clinical studies' time and cost. This, in turn will help bring new treatments to the market more quickly.

Allscripts eRecruit, the initial offering of Allscripts Clinical Trials Solutions, enables more effective clinical trials recruitment from Allscripts broad provider network and large patient population. eRecruit focuses specifically on helping CROs determine if a trial is feasible within the Allscripts population, and facilitating enrollment of the qualified patients the trial requires. The solution also assists with recruiting patients to participate in these studies through engagements with their providers. This offering provides an avenue for clinical research and life sciences organizations to better recruit for treatment research, providers to find relevant clinical trials for their patients, and patients to engage in innovative care.

Allscripts is partnering with ePatientFinder® to further eRecruit's patient matching, outreach and recruiting capabilities. The ePatientFinder Clinical Trial ExchangeTM platform helps physicians learn about the latest clinical trial options for their patients to provide high-quality referrals.

"We very excited to partner with Allscripts to provide their large provider base access to the Clinical Trial Exchange, the only platform of its kind that leverages the trusted physician-patient relationship and EHR data to match patients with trials for advanced care," said Tom Dorsett, CEO of ePatientFinder. "We applaud Allscripts for bringing eRecruit to both the provider and life-science communities."

"Allscripts eRecruit is the latest way that Allscripts is connecting communities to foster population health," said Jay Bhattacharyya, Allscripts Vice President and General Manager, Payer/Life Sciences. "Providers want to keep up with the latest research that helps improve patient outcomes. eRecruit helps providers better connect their patients to these clinical trials. We are excited to continue to expand our offerings in this space and lead the way in population health innovation."

About Allscripts
Allscripts (NASDAQ:MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of HealthTM. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

Most Popular Now

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...